Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia

PURPOSE: The aim of this study was to clarify whether early symptomatic improvement in response to a long-acting injectable antipsychotic (LAI) contributes to subsequent social functional remission in patients with schizophrenia using the previous clinical trial data (EudraCT registration number: 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohnishi, Takashi, Wakamatsu, Akihide, Kobayashi, Hisanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057833/
https://www.ncbi.nlm.nih.gov/pubmed/33888985
http://dx.doi.org/10.2147/NDT.S294503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057833/
https://www.ncbi.nlm.nih.gov/pubmed/33888985
http://dx.doi.org/10.2147/NDT.S294503

Ejemplares similares